Follow up of patients who start treatment with antidepressants: Treatment satisfaction, treatment compliance, efficacy and safety

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  López Torres, Jesús ^a   Párraga, Ignacio ^a   Del Campo, José M ^b   Villena, Alejandro ^c   Pretel, Fernando Andrés ^d   Simarro, Juan Miguel Armero ^d   Martínez, Rosa Armero ^d   Aguirregaviria, Francisco Javier Arribas ^d   Raya, Candelaria Ayuso ^d   Grass, Clotilde Boix ^d   Bermejo, Jesús Buendía ^d   Valenciano, Silvia Darias ^d   Molina, Rocío Pilar Elicegui ^d   Victor, Mariano Esbri ^d   Rabadán, Francisco Escobar ^d   Carreño, Ana Rus Galindo ^d   Becerra, Eva Facundo ^d   Pimpollo, Damarís Gómez ^d   Céspedes, Ma Dolores González ^d   Hidalgo, Enrique González ^d   Guardiola, Carlota Ibañez ^d   Callejo, Ángeles Lloret ^d   Gallardo, Yolanda López ^d   Pérez Romero, Marta Lucas ^d   Pérez Romero, Javier Lucas ^d   Garrido, Alejandro Manjavacas ^d   Jara, Inmaculada Marín ^d   Águeda, Belén Martín ^d   Gallardo, Carmen Martínez ^d   Ramírez, Miriam Martínez ^d   La Orden, Josefina Monedero ^d   Fernández, Julio Montoya ^d   Rayo, Susana Morena ^d   Bravo, Beatriz Navarro ^d   Sotos, Joseba Rabanales ^d   García, Ma Dolores Retuerta ^d   Nieto, Estrella Rivas ^d   Sáez, Adoración Romero ^d   Venceslá, Julián Pedro Ruano ^d   Barranco, Ignacio Sánchez ^d   Herráez, Ma José Simarro ^d   Lapeira, Juan Manuel Téllez ^d   González, Ma Isabel Tofiño ^d   more..

^a Research Unit   (Spain)

^b Health Care Service of Castilla La Mancha   (Spain)

^c Health Care Service of Castilla La Mancha   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HAMILTON SCALE; HAYNES SACKETT TEST; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICATION EVENT MONITORING SYSTEM; MONITORING; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MORISKY GREEN TEST; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREDICTION; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SELF REPORT; THE BELIEFS ABOUT MEDICINES QUESTIONNAIRE; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MEDICATION ADHERENCE; PATIENT SATISFACTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84873943125     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-65     Document Type: Article

References (51)

1. Ortiz Lobo A, Lozano Serrano C. El incremento en la prescripción de antidepresivos. Aten Primaria 2005, 35:152-155. 10.1157/13071941, 15737272.
2. Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, Magno ZJ. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998, 279:526-531. 10.1001/jama.279.7.526, 9480363.
3. Villalva Quintana E, Caballero Martínez L. Estudio sobre el uso y seguimiento del tratamiento con antidepresivos realizado por los médicos de Atención Primaria. SEMERGEN 2006, 32:427-432.
4. Martin-Agueda B, Lopez-Munoz F, Silva A, Garcia-Garcia P, Rubio G, Alamo C. Differences in management of depression in Spain from psychiatric and primary care physician point of view. Actas Esp Psiquiatr 2007, 35:89-98.
5. Subgrupos ATC y Principios activos de mayor consumo en el Sistema Nacional de Salud en 2009 2010, 34, Información Terapéutica del Sistema Nacional de Salud, http://www.msc.es/biblioPublic/publicaciones/recursos_propios/infMedic/docs/vol34n3SubgrATCppiosActivos.pdf.
6. Serna Arnáiz C, Galván Santiago L, Gascó Eguíluz E, Santafé Soler P, Martín Gracia E, Vila Parrot T. Evolución en el consumo de antidepresivos durante los años 2002 a 2004. Aten Primaria 2006, 38:456-460. 10.1157/13094803, 17194371.
7. Ufer M, Meyer SA, Junge O, Selke G, Volz HP, Hedderich J, Gleiter CH. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007, 16:1153-1160. 10.1002/pds.1405, 17443868.
8. Grunebaum MF, Oquendo MA, Manly JJ. Depressive symptoms and antidepressant use in a random community sample of ethnically diverse, urban elder persons. J Affect Disord 2008, 105:273-277. 10.1016/j.jad.2007.04.022, 2211422, 17532052.
9. Ortiz Lobo A, Lozano Serrano C, Fernández Jiménez G. La evolución de la prescripción y los costes de los antidepresivos en un área de Atención Primaria. SEMERGEN 2005, 31:456-461.
10. Double D. The limits of psychiatry. BMJ 2002, 324:900-904. 10.1136/bmj.324.7342.900, 1122838, 11950743.
11. Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF. Validity of clinical trials of antidepressants. Am J Psychiatry 2000, 157:327-337. 10.1176/appi.ajp.157.3.327, 10698806.
12. Kendrick T. Prescribing antidepressants in general practice. BMJ 1996, 313:829-830. 10.1136/bmj.313.7061.829, 2359037, 8870555.
13. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 2008, 5:e45. 10.1371/journal.pmed.0050045, 2253608, 18303940.
14. Moncrieff J, Wessely S, Hardy R. Placebos activos versus antidepresivos para la depresión. Cochrane Database Syst Rev 2011, http://www.bibliotecacochrane.com/BCPGetDocument.asp?SessionID=%202463166&DocumentID=CD003012.
15. Alonso MP, de Abajo FJ, Martinez JJ, Montero D, Martin-Serrano G, Madurga M. Evolution of antidepressive drug consumption in Spain. The impact of selective serotonin re-uptake inhibitors. Med Clin (Barc) 1997, 108:161-166.
16. Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the hypericum depression trial study group. J Clin Psychiatry 2011, 72:1669-1676. 10.4088/JCP.10m06453, 22053942.
17. MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 2003, 326:1014. 10.1136/bmj.326.7397.1014, 154760, 12742924.
18. Saiz Ruiz J, Montes Rodríguez JM. Tratamiento farmacológico de la depresión. Rev Clin Esp 2005, 205:233-240. 10.1157/13075575, 15970156.
19. Grupo de Trabajo sobre el Manejo de la Depresión Mayor en el Adulto Guía de Práctica Clínica sobre el Manejo de la Depresión Mayor en el Adulto 2008, Plan Nacional para el SNS del MSC. Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia (avalia-t), Madrid, Guías de Práctica Clínica en el SNS, http://www.guiasalud.es/GPC/GPC_424_Dep_Adult_compl.pdf, Grupo de Trabajo sobre el Manejo de la Depresión Mayor en el Adulto.
20. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry 2002, 180:104-109. 10.1192/bjp.180.2.104, 11823317.
21. De la Gándara JJ, Montejo González AL, Majadas Fernández S. Tratamiento de mantenimiento: la clave del éxito en la terapia de las depresiones. Psiq Biol 2004, 11:22-27.
22. Bousoño M, Fernández JM, Bobes J. Manifestaciones clínicas de los trastornos depresivos. Trastornos de ansiedad y trastornos depresivos en Atención Primaria 2000, 19-33. Masson, Barcelona, Bobes García J, Bousoño García M, Calcedo Barba A, González García-Portilla MP.
23. Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, Beasley CM, Michelson D, Roback P, Sundell K. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998, 155:1247-1253.
24. Lin EH, Von KM, Katon W, Bush T, Simon GE, Walker E, Robinson P. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995, 33:67-74. 10.1097/00005650-199501000-00006, 7823648.
25. Brown C, Battista DR, Sereika SM, Bruehlman RD, Dunbar-Jacob J, Thase ME. How can you improve antidepressant adherence?. J Fam Pract 2007, 56:356-363.
26. World Health Organization Adherence to long-term therapies. Evidence for action 2003, WHO Library Cataloguin-in-Publication Data, Switzerland, World Health Organization.
27. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000, 50:166-171. 10.1046/j.1365-2125.2000.00244.x, 2014396, 10930969.
28. Vermeire E, Hearnshaw H, Van RP, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001, 26:331-342. 10.1046/j.1365-2710.2001.00363.x, 11679023.
29. Myers ED, Branthwaite A. Out-patient compliance with antidepressant medication. Br J Psychiatry 1992, 160:83-86. 10.1192/bjp.160.1.83, 1544017.
30. Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 1995, 9(Suppl 4):33-40.
31. Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev 2000, 4:CD002791.
32. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995, 310:1433-1438. 10.1136/bmj.310.6992.1433, 2549813, 7613276.
33. Akincigil A, Bowblis JR, Levin C, Walkup JT, Jan S, Crystal S. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care 2007, 45:363-369. 10.1097/01.mlr.0000254574.23418.f6, 2882940, 17496721.
34. Burra TA, Chen E, McIntyre RS, Grace SL, Blackmore ER, Stewart DE. Predictors of self-reported antidepressant adherence. Behav Med 2007, 32:127-134. 10.3200/BMED.32.4.127-134, 17348428.
35. Wu CH, Erickson SR, Piette JD, Balkrishnan R. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Res Social Adm Pharm 2011,
36. Bosworth HB, Voils CI, Potter GG, Steffens DC. The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. Int J Geriatr Psychiatry 2008, 23:129-134. 10.1002/gps.1852, 17563920.
37. Badia X. Satisfaction with treatment. Med Clin (Barc) 2005, 125:98-99.
38. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M. Issues in the measurement of satisfaction with treatment. Am J Manag Care 1997, 3:579-594.
39. Linder-Pelz SU. Toward a theory of patient satisfaction. Soc Sci Med 1982, 16:577-582. 10.1016/0277-9536(82)90311-2, 7100990.
40. Carbonell J, Badia X. Development and validation of a satisfaction questionnaire in patients with rheumatoid arthritis. Reumatol Clin 2006, 2:137-145. 10.1016/S1699-258X(06)73035-2, 21794317.
41. Alomar A, Guerra A, Perulero N, Badía X, Canls L, Álvarez C. Desarrollo de un cuestionario de evaluación de la satisfacción con el tratamiento en pacientes con acné. Actas Demosifilogr 2004, 95:491-495.
42. Paddock LE, Veloski J, Chatterton ML, Gevirtz FO, Nash DB. Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care 2000, 23:951-956. 10.2337/diacare.23.7.951, 10895845.
43. Baro E, Casado A, Garcia-Cases C, Clerch L, Ribas S. Assessing satisfaction with pain medication in primary care patients: development and psychometric validation of a new measure. Clin Ther 2004, 26:1124-1136. 10.1016/S0149-2918(04)90185-3, 15336478.
44. Rebollo P, Cuervo J, Villa G, Barreda MJ, Tranche S, Sánchez-Baragaño MM, Prieto MA. Desarrollo y validación de un cuestionario genérico para la evaluación de la satisfacción de los pacientes crónicos: Cuestionrio SAT-Q. Aten Primaria 2010, 42:612-619. 10.1016/j.aprim.2009.12.008, 20304529.
45. Cifras de Población y Censos Demográficos 2007, Insituto Nacional de Estadística, Demografía y Población, http://www.ine.es/inebmenu/mnu_cifraspob.htm.
46. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
47. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
48. Ramos-Brieva JA, Cordero A. Validación de la versión castellana de la escala de Hamilton para la depresión. Actas Luso Esp Neurol Psiquiatr 1986, 14:324-334.
49. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389. 10.1192/bjp.134.4.382, 444788.
50. Martínez R, Bourgeois M, Peyre F, et al. Estudio de la validación de la escala de depresión de Montgomery y Asberg. Rev Asoc Esp Neuropsiq 1991, 11:9-14.
51. Beléndez Vázquez M, Hernández Mijares A, Horne R, Weinman J. Evaluación de las creencias sobre el tratamiento: validez y fiabilidad de la versión española del beliefs about medicines questionnaire. Int J Clin Health Psychol 2007, 7:767-779.